Guardian Asset Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$289K Buy
1,309
+142
+12% +$39.3K 0.13% 102
2026
Q1
$345K Sell
1,167
-119
-9% -$35.3K 0.2% 77
2025
Q4
$351K Sell
1,286
-15
-1% -$4.08K 0.18% 82
2025
Q3
$351K Sell
1,301
-12
-0.9% -$3.27K 0.19% 79
2025
Q2
$362K Buy
1,313
+146
+13% +$39.7K 0.21% 77
2025
Q1
$310K Buy
1,167
+8
+0.7% +$1.97K 0.2% 83
2024
Q4
$269K Buy
1,159
+1
+0.1% +$230 0.17% 88
2024
Q3
$256K Buy
1,158
+10
+0.9% +$2.07K 0.17% 91
2024
Q2
$226K Buy
1,148
+3
+0.3% +$620 0.17% 93
2024
Q1
$247K Buy
1,145
+6
+0.5% +$1.26K 0.2% 91
2023
Q4
$240K Buy
+1,139
New +$243K 0.22% 86

Other funds holding CME

Guardian Asset Advisors's CME Position: Q2 2026 in Review

Guardian Asset Advisors increased its CME Group (CME) stake by 12% in Q2 2026, buying an estimated $39.3K and bringing the position to 1,309 shares worth $289K. The position accounts for 0.13% of the portfolio, ranked #102.

Guardian Asset Advisors first reported a position in CME in Q4 2023 and has held it in 11 quarters since. The position peaked at $362K in Q2 2025. 490 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Guardian Asset Advisors held 1,309 shares of CME Group worth $289K as of Q2 2026.
  • Guardian Asset Advisors bought 142 CME Group shares in Q2 2026, an estimated $39.3K.
  • CME Group made up 0.13% of Guardian Asset Advisors's portfolio in Q2 2026, its #102 holding.
  • Guardian Asset Advisors first reported a position in CME Group in Q4 2023 and has held it in 11 quarters since.
  • Guardian Asset Advisors's CME Group position peaked at $362K in Q2 2025.
  • 490 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Guardian Asset Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.